Tirzepatide and Sulfur Burps: Understanding and Relief

Last Updated: MARCH 2026

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight loss, has revolutionized metabolic health management with its potent dual agonism of GLP-1 and GIP receptors. In the pivotal SURMOUNT-1 trial, tirzepatide demonstrated significant weight reduction, with participants on the 15 mg weekly dose achieving a mean weight loss of 20.9% from baseline at 72 weeks (1). This efficacy, however, often comes with gastrointestinal (GI) side effects, including the distinctive and often bothersome “sulfur burps.” These eructations, characterized by a rotten-egg smell, are a common, though usually transient, complaint among individuals initiating or escalating tirzepatide doses.

Understanding Sulfur Burps: The Science Behind the Smell

Sulfur burps are medically known as sulfurous eructation. Their distinctive odor comes from hydrogen sulfide (H₂S) gas, a compound naturally produced in the human digestive tract. H₂S is generated when gut bacteria ferment sulfur-containing organic compounds, primarily amino acids, found in food. While a small amount of H₂S is normal and even plays a signaling role in the body, an excess can lead to the unpleasant rotten-egg smell (3).

How Tirzepatide Contributes to Sulfur Burps

The primary mechanism by which tirzepatide—and other GLP-1 receptor agonists—induces sulfur burps is through its impact on gastric emptying.

1. Slowed Gastric Emptying: Both GLP-1 and GIP, the hormonal pathways mimicked by tirzepatide, are known to slow the rate at which food moves from the stomach into the small intestine. The FDA prescribing information for Mounjaro explicitly states, “Tirzepatide causes a delay of gastric emptying” (2). This delay means food, particularly nutrient-dense meals, remains in the stomach for longer periods.

2. Increased Fermentation: When food lingers in the stomach, it provides an extended opportunity for gastric bacteria (and refluxed intestinal bacteria) to ferment undigested food particles. This prolonged fermentation, especially of sulfur-containing proteins and complex carbohydrates, amplifies the production of H₂S gas. The gas accumulates in the stomach and is subsequently released as burps.

3. Dose-Dependent Effect: The slowing of gastric emptying is often dose-dependent. As tirzepatide doses are escalated (e.g., from 2.5 mg to 5 mg, or higher), the effect on gastric motility becomes more pronounced. This often correlates with an increase in the incidence and intensity of GI side effects, including sulfur burps. Patients frequently report that these burps are most noticeable when they first start tirzepatide or after a dose increase.

Incidence of Gastrointestinal Side Effects on Tirzepatide

Clinical trials for tirzepatide, such as the SURMOUNT program for weight loss and SURPASS program for type 2 diabetes, consistently report gastrointestinal adverse events. While “sulfur burps” or “halitosis” are not always listed as distinct categories, symptoms like nausea, vomiting, dyspepsia (indigestion), and eructation (belching) are frequently observed and are mechanistically linked to slowed gastric emptying.

For instance, in the SURMOUNT-1 trial for chronic weight management (1):

• Nausea: Reported in 24.6% of participants on 15 mg tirzepatide, 24.2% on 10 mg, and 23.3% on 5 mg, compared to 9.5% on placebo.
• Diarrhea: Experienced by 18.7% (15 mg), 16.2% (10 mg), and 17.1% (5 mg), versus 8.8% on placebo.
• Vomiting: Occurred in 9.8% (15 mg), 8.3% (10 mg), and 8.3% (5 mg), compared to 2.3% on placebo.
• Dyspepsia: Affecting 13.0% (15 mg), 12.3% (10 mg), and 9.4% (5 mg), versus 3.5% on placebo.
• Eructation (belching): While specific sulfur burp incidence is not parsed out, general belching is a reported symptom within these broader categories of GI discomfort.

These rates underscore that GI disturbances are a very common aspect of tirzepatide treatment, directly stemming from its pharmacological action. The FDA Prescribing Information for Zepbound explicitly notes that “Gastrointestinal adverse reactions were the most commonly reported adverse reactions” (5).

The following table summarizes the incidence of common GI adverse events observed in the SURMOUNT-1 trial for weight management:

(Source: Data derived from SURMOUNT-1 trial results, N Engl J Med. 2022)

Dietary Triggers: Foods That Fuel Sulfur Burps

Certain foods are known to contribute more significantly to hydrogen sulfide production due to their sulfur content or their effect on gut fermentation. Reducing or temporarily eliminating these can help alleviate sulfur burps:

• High-Sulfur Foods:
  • Cruciferous Vegetables: Broccoli, cauliflower, cabbage, Brussels sprouts. These are healthy but contain sulfur compounds that can be fermented.
  • Alliums: Onions, garlic, leeks, chives.
  • Eggs: A well-known source of sulfur.
  • Red Meat and Processed Meats: High in sulfur-containing amino acids.
  • Dairy Products: Milk, cheese, yogurt, especially for individuals with lactose intolerance.
  • Certain Legumes: Beans, lentils.
  • Some Fruits: Dried fruits, bananas.
• High-Fat Foods: Fatty foods naturally slow gastric emptying, independently of tirzepatide. Combining a high-fat diet with tirzepatide can exacerbate the stomach-emptying delay, leading to more fermentation and burps.
• Sugary and Highly Processed Foods: Can feed undesirable gut bacteria, promoting fermentation.
• Carbonated Beverages: Introduce excess gas into the stomach, which can be released as burps.

Strategies to Reduce Sulfur Burps on Tirzepatide

Managing sulfur burps often involves a combination of dietary adjustments and lifestyle changes, all aimed at minimizing gastric fermentation and facilitating gas passage.

1. Modify Your Diet: * Reduce Sulfur-Rich Foods: Temporarily limit or avoid the foods listed above, particularly around the time of your injection or when symptoms are most pronounced. Reintroduce them gradually to identify personal triggers. * Opt for Smaller, More Frequent Meals: Overloading the stomach with large meals further slows emptying. Eating smaller portions more frequently can help manage the digestive load. * Limit High-Fat Foods: Choose leaner protein sources and reduce intake of fried foods, creamy sauces, and fatty cuts of meat. * Stay Hydrated: Drinking plenty of water aids digestion and can help dilute stomach contents, potentially reducing fermentation. * Ginger: Ginger is a natural prokinetic agent that can help stimulate gastric emptying and is known to alleviate nausea (4). Incorporate ginger tea or small amounts of fresh ginger into your diet. * Peppermint: Peppermint can relax the GI tract and alleviate gas. Peppermint tea might be helpful.

2. Improve Eating Habits: * Eat Slowly and Mindfully: Rushing meals can lead to swallowing excess air, contributing to burping. Chew your food thoroughly. * Avoid Talking While Eating: This also reduces air intake. * Limit Carbonated Drinks: Stick to still water or unsweetened herbal teas. * Avoid Lying Down Immediately After Eating: Remain upright for at least 2-3 hours after meals to aid digestion and prevent reflux.

3. Consider Over-the-Counter Aids: * Simethicone: Anti-gas medications containing simethicone (e.g., Gas-X, Mylanta Gas) work by breaking down gas bubbles in the digestive tract, making them easier to pass. These can offer temporary relief. * Bismuth Subsalicylate: Products like Pepto-Bismol can absorb hydrogen sulfide gas and reduce the foul odor. * Digestive Enzymes: Some individuals find relief with broad-spectrum digestive enzyme supplements, especially those containing amylase, protease, and lipase, to help break down food more efficiently. * Probiotics: While research is ongoing, certain probiotic strains may help rebalance gut microbiota, potentially reducing the production of H₂S. Look for strains like Lactobacillus and Bifidobacterium.

4. Adjust Tirzepatide Administration (with professional guidance): * Injection Site: Anecdotal reports suggest that some individuals experience fewer GI side effects when injecting in different sites (e.g., abdomen vs. thigh). This is not scientifically proven but could be explored with your healthcare provider. * Dose Timing: Some individuals find injecting in the evening helps mitigate daytime side effects, as the peak effects of gastric slowing may occur while they sleep. * Dose Titration: Ensuring a slow and steady dose escalation, allowing the body ample time to adapt, is crucial for minimizing side effects. Do not attempt to rapidly increase your dose.

When to Consult a Healthcare Provider

While sulfur burps are typically benign and manageable, it is important to be aware of symptoms that warrant medical attention. If sulfur burps are accompanied by severe or persistent symptoms such as:

• Intense abdominal pain
• Persistent vomiting or diarrhea leading to dehydration
• Difficulty swallowing
• Unexplained weight loss (beyond the expected effect of tirzepatide)
• Bloody stools or black, tarry stools

These could indicate a more serious underlying condition or a need to re-evaluate your tirzepatide treatment plan.

Conclusion

Sulfur burps are a common, though often embarrassing, side effect for many individuals taking tirzepatide. They are a direct consequence of the medication’s therapeutic mechanism: slowed gastric emptying leading to increased bacterial fermentation and hydrogen sulfide production. By understanding these physiological processes and implementing targeted dietary and lifestyle modifications, most individuals can effectively manage and significantly reduce the occurrence of these unpleasant burps, allowing them to continue benefiting from tirzepatide’s significant metabolic advantages.

Sources

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. DOI: 10.1056/NEJMoa2206038
2. U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised May 2022. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
3. Levitt MD, et al. Effects of diet on intestinal gas production. Aliment Pharmacol Ther. 2021 Jul;54(2):162-172. DOI: 10.1111/apt.16439
4. Hu ML, et al. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011 Jan 7;17(1):105-10. DOI: 10.3748/wjg.v17.i1.105
5. U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised November 2023. Available at: https://www.accessdata.fda.gov/drugsatfda_docs